Table 1_Inconsistent medication recommendations for immune-mediated inflammatory diseases

A guideline-based review analyzes inconsistencies in medication recommendations for immune-mediated inflammatory diseases across perinatal contexts. The study examined 11 leading international guidelines published between 2015 and 2025 from gastroenterology, rheumatology, and dermatology specialties. Author Elise Van den Broeck published the findings in March 2026.

Use Cases

• Quantifying guideline consistency rates based on the reported percentages for within-specialty and cross-specialty agreement.
• Identifying medication classes with insufficient safety data based on the reported prevalence of inconsistencies stemming from data gaps.
• Analyzing trimester-specific recommendation patterns based on the reported 33.3% consistency rate for such recommendations.
• Comparing preconception discontinuation timing guidance based on the reported agreement rates for maternal and paternal cases.

Strengths

• Analysis is based on 11 leading international guidelines, providing a multi-specialty perspective.
• Reports specific consistency percentages, such as 82.4% for gastroenterology and 60.6% for dermatology within specialties.
• Identifies concrete contributors to inconsistency, with 59.5% stemming from insufficient safety data reporting.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is a 52.9 KB DOCX file, indicating a limited scope focused on review findings rather than raw guideline data.

Provenance

Source

figshare, author Elise Van den Broeck.

Collection Method

Review conducted in August 2025 using most recent versions of 11 international guidelines.

Time Range

Guidelines published between 2015 and 2025.

Freshness

Last updated 2026-03-17 13:05:11; freshness should be verified.

Geography

International guidelines; specific geography not stated.